Skip to main content
. 2020 Jul 9;14:1753466620937194. doi: 10.1177/1753466620937194

Figure 4.

Figure 4.

Forrest plot comparing LABA/LAMA FDCs and LAMAs with events of moderate-to-severe exacerbations.

CI, confidence interval; FDC, fixed-dose combination; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonist.

HHS Vulnerability Disclosure